Scientific Publications about Covid-19

A list of papers by STRATAGEM members, contributing to the joint effort for better understanding COVID-19-related issues

After publication of Covid-19-related research, please send the citation to yyordanov@pharmfac.mu-sofia.bg formatted as in the following list:

1. Morselli M, Farrell C, Montoya D, Gören T, Sabırlı R, Türkçüer İ, Kurt Ö, Köseler A, Pellegrini M. DNA methylation profiles in pneumonia patients reflect changes in cell types and pneumonia severit. Epigenetics. 2022; doi: 10.1080/15592294.2022.2051862
2. Karsli E, Sabirli R, Altintas E, Canacik O, Sabirli GT, Kaymaz B, Kurt Ö, Koseler A. Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study. Life Sciences. 2021,  277, 119634; doi: 10.1016/j.lfs.2021.119634
3. E Mete, R Sabirli, T Goren, I Turkcuer, Ö Kurt, A Koseler. Association Between S100b Levels and COVID-19 Pneumonia: A Case Control Study. In Vivo. 2021, 35 (5) 2923-2928; doi: doi.org/10.21873/invivo.12583
4. Canacik O, Sabirli R, Altintas E, Karsli E, Karis D, Kaymaz B, Sabirli GT, Kurt Ö, Koseler A. Annexin A1 as a potential prognostic biomarker for COVID‐19 disease: Case–control study. Int J Clin Pract. 2021, e14606; doi: 10.1111/ijcp.14938
5. Fallani E, Cevenini F, Lazzerini PE, Verdini A, Saponara S. Off-label use of hydroxychloroquine in COVID-19: analysis of reports of suspected adverse reactions from the Italian National Network of Pharmacovigilance. J Clin Pharmacol. 2021; doi: doi.org/10.1002/jcph.2006
6. Kivrak A, Ulaş B, Kivrak H. A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2. International Immunopharmacology. 2021, 90; doi: 10.1016/j.intimp.2020.107232
7. Vasconcelos M H, Alcaro S, Arechavala-Gomeza V, Baumbach J, Borges F, Brevini T A L , De Las Rivas J, Devaux Y, Hozak P, Keinänen-Toivola M M, Giovanna Lattanzi G, Mohr T, Murovska M, Prusty B K, Quinlan R A, Pérez-Sala D, Scheibenbogen C, Schmidt H H W, Silveira I, Tieri P, Tolios A, Riganti C. Joining European Scientific Forces to Face Pandemics. Trends in Microbiology. 2020; doi: 10.1016/j.tim.2020.10.008
8. Sabirli R, Koseler A, Goren T, Turkcuer I, Kurt O. High GRP78 levels in Covid-19 infection: A case-control study. Life Sciences. 2020, doi: 10.1016/j.lfs.2020.118781
9. Palmeira A, Sousa E, Köseler A, Sabirli R, Gören T, Türkçüer İ, Kurt Ö, Pinto M, Vasconcelos MH. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13(6), 132; doi: 10.3390/ph13060132
10. Köseler A, Sabirli R, Gören T, Türkçüer İb, Kurt Ö. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.  in vivo 2020, 34.
11. Erin N. Recent therapeutic approaches for treatment of covid-19 and the necessary precautions. Turkish Academia of Science, Report on COVID-19 pandemic (TÜBA COVID-19 Küresel Salgın Değerlendirme Raporu) 2020, 175-177; ISBN: 978-605-2249-43-7